Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Hepatol. Jan 27, 2022; 14(1): 209-223
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.209
Table 2 Univariate analysis of factors associated with overall survival
Variable
HR
95%CI
P value
Age 1.0150.984-1.0470.350
Sex
MaleRef
Female1.2590.733-1.1620.405
Location of primary tumor
RectumRef
Right1.5420.780-3.0480.213
Left 1.3700.737-2.5450.319
Regional LN metastasis
NoRef
Yes1.4440.836-2.4920.187
Time of diagnosis of liver metastasis, %
SynchronousRef
Metachronous
Disease-free interval < 12 mo0.8140.317-2.0940.670
Disease-free interval ≥ 12 mo0.7500.416-1.3520.338
Synchronous extrahepatic metastasis
NoRef
Yes1.8840.253-14.00.536
Preoperative CEA level
< 200 ng/mLRef
≥ 200 ng/mL1.1040.392-3.1110.851
Systemic chemotherapy before liver resection
NoRef
Yes1.1040.439-2.7760.833
Number of liver metastases
< 5 lesionsRef
≥ 5 lesions2.5061.124-5.5850.025a
Size of the largest liver lesion
< 4 cmRef
≥ 4 cm1.6450.934-2.8960.085
Surgical margin
ClearRef
Involved0.9650.509-1.8290.912
Concurrent ablation
NoRef
Yes1.4490.573-3.6630.434
Operative approach
LaparoscopicRef
Open1.0690.624-1.8320.808
Intraoperative blood loss, %
< 500 mLRef
≥ 500 mL1.8450.985-3.4570.056
Requirement of blood transfusion, %
NoRef
Yes1.3260.712-2.4720.374